Deutsche Bank Ag\ Cue Biopharma, Inc. Transaction History

Deutsche Bank Ag\

$218 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.72 - $3.1 $47,217 - $85,101	27,452 Added 1168.67%	29,801 $78,000
Q3 2023 Nov 09, 2023	BUY	$2.23 - $4.69 $5,238 - $11,016	2,349 New	2,349 $5,000
Q2 2022 Aug 11, 2022	SELL	$2.49 - $5.92 $55,527 - $132,016	-22,300 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$4.41 - $12.28 $5,005 - $13,937	-1,135 Reduced 4.84%	22,300 $108,000
Q4 2021 Feb 11, 2022	BUY	$10.86 - $17.85 $6,516 - $10,710	600 Added 2.63%	23,435 $265,000
Q3 2021 Nov 04, 2021	SELL	$10.06 - $15.3 $89,433 - $136,017	-8,890 Reduced 28.02%	22,835 $333,000
Q2 2021 Aug 11, 2021	BUY	$10.9 - $14.53 $35,261 - $47,004	3,235 Added 11.35%	31,725 $370,000
Q1 2021 May 13, 2021	SELL	$11.2 - $16.09 $102,603 - $147,400	-9,161 Reduced 24.33%	28,490 $0
Q4 2020 Feb 16, 2021	BUY	$11.12 - $16.4 $149,063 - $219,841	13,405 Added 55.29%	37,651 $471,000
Q3 2020 Nov 12, 2020	BUY	$15.05 - $23.54 $93,520 - $146,277	6,214 Added 34.46%	24,246 $365,000
Q2 2020 Aug 13, 2020	BUY	$12.7 - $30.73 $137,985 - $333,881	10,865 Added 151.6%	18,032 $442,000
Q1 2020 May 14, 2020	SELL	$9.85 - $22.27 $758 - $1,714	-77 Reduced 1.06%	7,167 $102,000
Q4 2019 Feb 14, 2020	BUY	$7.06 - $17.47 $10,477 - $25,925	1,484 Added 25.76%	7,244 $114,000
Q3 2019 Nov 14, 2019	SELL	$6.78 - $9.28 $54,572 - $74,694	-8,049 Reduced 58.29%	5,760 $46,000
Q2 2019 Aug 14, 2019	SELL	$7.18 - $9.65 $64,720 - $86,985	-9,014 Reduced 39.5%	13,809 $123,000
Q1 2019 May 15, 2019	SELL	$4.7 - $9.29 $1,273 - $2,517	-271 Reduced 1.17%	22,823 $175,000
Q4 2018 Feb 14, 2019	SELL	$4.35 - $8.73 $74,197 - $148,907	-17,057 Reduced 42.48%	23,094 $107,000
Q3 2018 Dec 21, 2021	BUY	$7.91 - $11.89 $36,828 - $55,359	4,656 Added 13.12%	40,151 $364,000
Q3 2018 Nov 14, 2018	BUY	$7.91 - $11.89 $12,845 - $19,309	1,624 Added 4.79%	35,495 $320,000
Q2 2018 Apr 21, 2020	BUY	$10.93 - $14.48 $62,716 - $83,086	5,738 Added 20.4%	33,871 $402,000
Q2 2018 Aug 14, 2018	BUY	$10.93 - $14.48 $182,574 - $241,873	16,704 Added 146.15%	28,133 $333,000
Q1 2018 Oct 18, 2019	BUY	$11.63 - $17.25 $23,725 - $35,190	2,040 Added 21.73%	11,429 $159,000
Q1 2018 May 15, 2018	BUY	$11.63 - $17.25 $109,194 - $161,960	9,389 New	9,389 $131,000

Others Institutions Holding CUE

# of Institutions

Shares Held

13.8M

Call Options Held

56.1K

Put Options Held

11.1K

Bleichroeder LP New York, NY

2.86M
Shares

$2.17 Million
1.28% of portfolio
Slate Path Capital LP New York, NY

2.4M
Shares

$1.83 Million
0.06% of portfolio
Vanguard Group Inc Valley Forge, PA

2.03M
Shares

$1.54 Million
0.0% of portfolio
Black Rock Inc. New York, NY

757K
Shares

$575,119
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

494K
Shares

$375,430
0.0% of portfolio

View Full List

About Cue Biopharma, Inc.

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $26.9M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

More about CUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account